Pharmaceutical Care dan Farmasi Klinik

Farmasi klinik adalah suatu disiplin ilmu kesehatan di mana farmasis memberikan asuhan (“care”; bukan hanya jasa pelayanan klinis) kepada pasien dengan tujuan untuk mengoptimalkan terapi obat dan mempromosikan kesehatan, wellness dan prevensi penyakit.

Clinical Pharmacy is a health science discipline in which pharmacists provide patient care that optimizes medication therapy and promotes health, wellness, and disease prevention : see http://www.accp.com/about/clinicalPharmacyDefined.aspx)

I Infark Miokard Akut

   Hipertensi

   Obat Dislipidemia

   Obat Gout dan GOUT update farmakoterapi

   Obat Emergensi Urologis 

II  Peran Farmasis dalam Pengkajian Perawatan Pasien

     Pertimbangan Budaya dalam Pengkajian Pasien

     Kesehatan dan Riwayat Pengobatan

     Prinsip dan Metode Pemeriksaan Fisik Dasar

     General Assesment dan Vital Signs

     Penilaian Status Nutrisi

     Penilaian (Assessment) Nyeri

     Kulit, Rambut, Kuku

     Sistem Pembuluh Daraf Perifer

III  Presentasi Kasus

       Dokumentasi Intervensi Farmasis

IV Keterampilan Komunikasi pada Praktek Farmasi, Wawancara Pasien

V   Buku Sistem Pernafasan hibah lp3 (tugas PSF FKUB)

     Gagal jantung –lilly

     Modul HTNHFSyok (Hipertensi, Gagal Jantung, Syok) (tugas PSF FKUB)

     Modul Farmakoterapi Hepatitis BC dan Sirosis hibah lp3 modul (tugas PSF FKUB)

     Modul Infeksi pada Pasien dengan Malignansi (PHKA1PSF-FKUB)

     Terapi breast cancer

VI  Gangguan Cairan dan Elektrolit (pediatrik)

    Gangguan Keseimbangan Asam Basa (pediatrik)

    Gangguan Metabolisme Ion Divalen (pediatrik)

    Hipertensi (pediatrik)

    Gagal Ginjal Akut/Acute Renal Failure (pediatrik)

    Penyakit Ginjal Kronik CKD (pediatrik)

    Nefritis Herediter (pediatrik)

    Penyakit Glomerula, Vaskular, Tubulointerstisial (pediatrik)

    End Stage Renal Disease dan Dialisis (pediatrik)

    Osteodistrofi Renal (pediatrik)

    Transplantasi Ginjal (pediatrik)


Some of the pdf are contributed by colleagues physician, pharmacist and biologists:

Ni Luh Made Agustini Leonita

Benediktus Yohan

Chris Adhiyanto

Mohamad Rusdi

Eva Manulang

Windy Joanmawanti

Agung Megawati

Sukma Oktavianti

Original articles can be found in

Patient Assessment in Pharmacy Practice (Rhonda M. Jones, Raylene M. Rospond)
 
Publications
14_RJPT_10_8_2017 Post Marketing Study of Ponstan®500 mg Tablet under Suspicion as Counterfeit Drug at Pharmacies (Asri Rachmadi 1, Diana Lyrawati 2*, Adeltrudis Adelsa Danimayostu 3)
diana.l@ub.ac.id , eldi_7_98@yahoo.com , diana.lyrawati@gmail.com
1 Pharmacy Study Program, Faculty of Medicine, Brawijaya University, Malang, Indonesia
2 Department of Clinical Pharmacy, Faculty of Medicine, Brawijaya University, Malang, Indonesia
3 Department of Pharmaceutics, Faculty of Medicine, Brawijaya University, Malang, Indonesia
*Corresponding Author
DOI No: 10.5958/0974-360X.2017.00444.9

ABSTRACT:

Ponstan® (Mefenamic Acid 500 mg) is one of a few commonly counterfeited drugs in Indonesia. Drug counterfeiting would adversely affect consumers in terms of finances and health. Local health authority rarely conducted market inspection to address such problem. This study was conducted to determine whether Ponstan® sold at pharmacies in the vicinity of public hospital were counterfeit drugs, based on tablets physical characteristics and active substance contents with regards of the Pharmacopeia Indonesia 4th Edition requirements. This study used Ponstan® sampled from pharmacies within 1 kilometer radius of Class A or B public hospitals in Malang. The packages and tablets were physically inspected, and mefenamic acid assayed by using spectrophotometric method at 285 nm. All of the samples showed similar physical characteristics when compared to the original Ponstan®. Of total 66 tablets collected from 22 pharmacies, mefenamic acid contents were ranging from 94.58% to 111.72% of that listed on their labels, with 3.03% (2/66) contained more than 110%. It can be concluded that 96.97% (64/66) of Ponstan® tablets collected from sampled pharmacies meet the requirements of Pharmacopeia Indonesia 4th Edition, whereas the other 3.03% belong to “not conformed product” during quality control inspection.
KEYWORDS: Ponstan®, counterfeit, pharmacies, hospital, spectrophotometry.
Cite: Asri Rachmadi, Diana Lyrawati, Adeltrudis Adelsa Danimayostu. Post Marketing Study of Ponstan®500 mg Tablet under Suspicion as Counterfeit Drug at Pharmacies. Research J. Pharm. and Tech. 2017; 10(8): 2507-2509.



Advertisements

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: